English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/181419
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach

AuthorsChalbatani, Ghanbar Mahmoodi; Dana, Hassan; Gharagouzloo, Elahe; Grijalvo, Santiago; Eritja Casadellà, Ramón; Logsdon, Craig D.; Memari, Fereidoon; Rouhollah Miri, Seyed; Rezvani Rad7, Mahdi; Marmari, Vahid
KeywordsDelivery strategies
Lipoplexes
Nanovectors
Polymeric nanoparticles
siRNA
Issue Date2-May-2019
PublisherDove Press
CitationInternational Journal of Nanomedicine 14: 3111-3128 (2019)
AbstractCancer is one of the most complex diseases that has resulted in multiple genetic disorders and cellular abnormalities. Globally, cancer is the most common health concern disease that is affecting human beings. Great efforts have been made over the past decades in biology with the aim of searching novel and more efficient tools in therapy. Thus, small interfering RNAs (siRNAs) have been considered one of the most noteworthy developments which are able to regulate gene expression following a process known as RNA interference (RNAi). RNAi is a post-transcriptional mechanism that involves the inhibition of gene expression through promoting cleavage on a specific area of a target messenger RNA (mRNA). This technology has shown promising therapeutic results for a good number of diseases, especially in cancer. However, siRNA therapeutics have to face important drawbacks in therapy including stability and successful siRNA delivery in vivo. In this regard, the development of effective siRNA delivery systems has helped addressing these issues by opening novel therapeutic windows which have allowed to build up important advances in Nanomedicine. In this review, we discuss the progress of siRNA therapy as well as its medical application via nanoparticle-mediated delivery for cancer treatment.
Publisher version (URL)https://doi.org/10.2147/IJN.S200253
URIhttp://hdl.handle.net/10261/181419
DOI10.2147/IJN.S200253
Appears in Collections:(IQAC) Artículos
Files in This Item:
File Description SizeFormat 
Small interfering RNAs (siRNAs) in cancer.pdf1,65 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.